SEC Form D · filed March 3, 2017
Orexigen Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (29)
Thomas Lynch · La Jolla, CAExecMichael Narachi · La Jolla, CAExec · DirectorBrian H. Dovey · La Jolla, CADirectorThomas Cannell · La Jolla, CAExecDavid J. Endicott · La Jolla, CADirectorLouis C. Bock · La Jolla, CADirectorPatrick J. Mahaffy · La Jolla, CADirectorPeter K. Honig · La Jolla, CADirectorLota S. Zoth · La Jolla, CADirectorPeter Flynn · La Jolla, CAExecPatrick J. Mckinney · Bloomington, MNDirectorLeonardus H.T. Van Der Ploeg · Los Altos, CADirectorRobert P. Thorbus · Bloomington, MNDirectorMaryrose N. Mallari · Bloomington, MNDirectorGeorge Lobisser · Bainbridge Island, WAExecDeborah S. Jorn · La Jolla, CADirectorJason S. Keyes · La Jolla, CAExecReinhold P. Henke · Bloomington, MNDirectorJim Eberhard · Bozeman, MTExec · DirectorDavid Breck · Bozeman, MTDirectorDavid Sigler · Bozeman, MTExec · DirectorJohn F. Warnken-Brill · SAN FRANCISCO, CADirectorBrian F. Sheth · SAN FRANCISCO, CAExec · DirectorDaniela Taplin Lundberg · Westport, CTDirectorLawson D. Devries · Raleigh, NCExecPratima Sharma · Plano, TXExecDeborah S. Jorn · La Jolla, CADirectorJason S. Keyes · La Jolla, CAExecPeter Flynn · Vancouver, British Columbia, CanadaExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗